A new collaboration to tackle the biggest health challenges faced by the West Midlands’ six million residents will use real-time clinical trials and health data to speed up research and improve cancer care, maternity services, child health, obesity, and dementia.
Public Health England has published its evidence review of dependence and withdrawal problems associated with five commonly prescribed classes of medicines in England.
Government has published the documents relating to 'Operation Yellowhammer' with planning assumptions for a 'no-deal' Brexit.
Health Data Research UK has announced the locations of seven new digital innovation hubs that will help the UK make the most of health-related data for future research and development into new medicines.
The ABPI has launched new guidance to make sure that joint working between the NHS and industry delivers ‘a triple win’ in benefits for patients, the NHS and companies.
NICE has announced that CEO Sir Andrew Dillon is to step down at the end of March next year.
In response to concerns about the impact a US trade deal would have on medicine pricing, the ABPI continues to emphasise that in the UK, we have very strict rules which control medicine spend.
The Prime Minister has demanded urgent action to tackle declining vaccination rates for MMR. This is the right approach, says Dr Sheuli Porkess of the ABPI.
The Department of Health and Social Care is leading a procurement exercise for an express freight service as part of the government’s plans to support continuity of supply when the UK leaves the EU on 31 October.
The Prime Minister has announced proposals to shake up immigration rules to help attract scientists to the UK.